S&P assigns ‘A+’ rating to RWJBarnabas Health’s bonds

S&P Global Ratings has assigned an “A+” rating to West Orange, N.J.-based RWJ Barnabas Health’s $613 million of series 2016A bonds.

Advertisement

“The rating reflects our assessment of RWJBarnabas Health’s geographic and financial diversity of system assets, solid statewide market share, financial metrics that are in line with the higher rating level, benefits of the debt restructuring, commitment to profitable ambulatory expansion within the system and into adjacent service areas, management team with proven turnaround skills and generally favorable service area demographics,” said S&P analyst Cynthia Keller.

The outlook is stable, reflecting S&P’s expectation that RWJBarnabas Health will achieve sufficient integration savings to offset industry pressure on revenue and expenses.

More articles on healthcare finance:
Miami Children’s Health System taps Cerner for RCM services
Kentucky hospitals see uncompensated care drop 77% since 2012
Southeast rural health facilities choose Azalea Health for medical billing and EHR

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.